SCHEMBL5862769

SCHEMBL5862769

CN(Cc1oc(-c2ccc(C(F)(F)F)cc2)cc1CO)C1CCCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.42
HRH4 Q9H3N8 1/20 0.42
TRPV1 Q8NER1 2/20 0.36
CYP2D6 P10635 3/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C19 P33261 2/20 0.36
MCHR1 Q99705 4/20 0.36
ALDH1A1 P00352 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
PRMT1 Q99873 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
NSD2 O96028 1/20 0.35
MPI P34949 1/20 0.35
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CHEK1 O14757 1/20 0.35
NTRK1 P04629 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6164377 0.80 PPARD (0.41) HRH3HRH4CYP2D6CYP1A2CYP2C19
SCHEMBL5861037 0.79 PRMT1 (0.37) TRPV1CYP2D6CYP1A2CYP2C19PRMT1
SCHEMBL6164370 0.78 PPARD (0.41) HRH3HRH4ALDH1A1
SCHEMBL6162606 0.77 CYP3A4 (0.41) CYP2D6CYP1A2CYP2C19PRMT1CDK8
SCHEMBL3111585 0.77 CYP1A1 (0.43) CYP2D6CYP1A2CYP2C19MAPTPRMT1
SCHEMBL3110083 0.76 TRPV1 (0.40) TRPV1CYP2D6CYP1A2CYP2C19SMN1; SMN2
SCHEMBL5861739 0.76 CYP1A1 (0.40) TRPV1CYP2D6CYP1A2CYP2C19MCHR1
Hydrochloric Acid SCHEMBL5862770 0.75 PPARD (0.59)
SCHEMBL5861211 0.74 CYP1A1 (0.41) TRPV1CYP2D6CYP1A2CYP2C19ALDH1A1
SCHEMBL5862035 0.74 PRMT1 (0.40) CYP2D6CYP1A2CYP2C19ALDH1A1PRMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7091237-B2 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors SMITHKLINE BEECHAM CORPORATION (US) 2006-08-15 US disclosed
EP-1392674-B1 FURAN AND THIOPHENE DERIVATIVES THAT ACTIVATE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS SMITHKLINE BEECHAM CORP (US) 2005-08-10 EP disclosed
US-20040157890-A1 Furan and thiophene derivatives that activate human peroxisome profilerator activated receptors GLAXO GROUP LIMITED (GB) 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157890-A1 Furan and thiophene derivatives that activate human peroxisome profilerator activated receptors PPARG, PPARD, PPARA HRH3 1269/4885HRH4 413/4885TRPV1 272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.